Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.

@article{Song2016PrognosticVO,
  title={Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.},
  author={Ki Byung Song and Song Cheol Kim and Ji Hun Kim and Dong-Wan Seo and Seung-Mo Hong and K. Y. Park and Dae Wook Hwang and Jae Hoon Lee and Young-Joo Lee},
  journal={Pancreas},
  year={2016},
  volume={45 2},
  pages={
          187-92
        }
}
OBJECTIVES Studies on the expression of somatostatin receptor (SSTR) subtypes in pancreatic neuroendocrine tumors (PNETs) are rare. The aim of this study was to determine the expression of the SSTR subtypes via immunohistochemistry analyses and assess the correlation between SSTR subtype expression and prognosis. METHODS We examined 199 patients with PNET who underwent surgical resection between January 1995 and December 2010 at the Asan Medical Center. For all cases, medical records… CONTINUE READING
BETA
1
Twitter Mention

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-6 OF 6 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Clinical significance of protein expression of cyclooxygenase-2 and somatostatin receptors in gastroenteropancreatic neuroendocrine tumors

HS Kim, HS Lee, WH. Kim
  • Cancer Res Treat. 2011;43:181–188
  • 2015

) , the Hochwald grading system , and AJCC and ENETS staging systems in predicting prognosis in locoregional welldifferentiated pancreatic neuroendocrine tumors

W Bauer, U Briner, W Doepfner
  • Am J Surg Pathol
  • 2013